Open-Label Extension Studies: Are They Really Research?

ISSN： 1536-0075

Source： American Journal of Bioethics, Vol.14, Iss.4, 2014-04, pp. : 60-61

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

When Should Open-Label Extension Studies Be Stopped?

By Crites Joshua S.

American Journal of Bioethics, Vol. 14, Iss. 4, 2014-04 ,pp. : 57-58

Routledge Ltd

Access to resources Recommend Favorite

Ethics of Continuing to Provide a Drug on an Open-Label Extension Study for an “Unapproved Indication”

By Taylor Holly A. Kuwana Ellen Wilfond Benjamin S.

American Journal of Bioethics, Vol. 14, Iss. 4, 2014-04 ,pp. : 56-56

Routledge Ltd

Access to resources Recommend Favorite

The Role of Clinical Equipoise and Practical Considerations in Deciding Whether to Continue to Provide a Drug on an Open-Label Extension Study for an “Unapproved Indication”

By Nash Ryan R.

American Journal of Bioethics, Vol. 14, Iss. 4, 2014-04 ,pp. : 59-60

Routledge Ltd

Access to resources Recommend Favorite

The Relevance of Research Study Phase to Disclosure of Off-Label Drug Availability

By Baskaran Amrutha Sade Robert M.

American Journal of Bioethics, Vol. 14, Iss. 4, 2014-04 ,pp. : 53-54

Routledge Ltd

Access to resources Recommend Favorite

The Ethics of Disclosing to Research Subjects the Availability of Off-Label Marketed Drugs

By Taylor Holly A. Kuwana Ellen Wilfond Benjamin S.

American Journal of Bioethics, Vol. 14, Iss. 4, 2014-04 ,pp. : 51-51

Routledge Ltd

Access to resources Recommend Favorite